In a Nature news article on the effectiveness of immunotherapy in treating patients with prostate cancer, Julie Graff, M.D., says: “Prostate cancers are like an onion: there are so many barriers to the immune system, and you must start peeling them away.”

STAT interviews Jeff Kaye, M.D., about the results of a new study that suggest slight improvements in cognition and memory among older adults taking a common multivitamin over three years. Kaye cautions, “You could score a point better when you take the test a year later, and it’s statistically significant. But does that translate into anything meaningful in a person’s life?”

Becker's Hospital Review covers the appointment of Qiana Williams as OHSU's first Chief People Officer and EVP; her appointment also is mentioned in two Becker's Hospital Review articles: "27 recent hospital, health system executive moves" and "13 women making moves in healthcare."

Projects led by Shannon McWeeney, Ph.D., David Dorr, M.D., M.S., and Kyle Ellrott, Ph.D., received funding from the NIH’s Bridge2AI program to support the widespread adoption of artificial intelligence in biomedical research to address ambitious issues facing researchers today.

Amy Cantor, M.D., M.P.H., is interviewed on OPB-Radio’s “Think Out Loud” program about her recently published study that found counseling as an effective method to prevent obesity in midlife women, ages 40 to 60. She says, “I think the message is that clinicians should have an awareness of the services so that they can provide them to their patients. And on the flip, that patients understand that these services are things they have access to.”

Brian O’Roak, Ph.D., and Marissa Co, Ph.D., talk about new research, published in The Journal of Neuroscience, revealing similar structural changes in the brains of mice and people with autism spectrum disorder caused by mutations in the TBR1 gene. Co references the next step of research, saying, “It would be interesting to compare not just social deficits, but also anxiety and aggression, which are seen in individuals with TBR1 mutations.”

PDX Parent readers submitted their "top choices in the Pregnancy and Baby categories" for 2022, and OHSU Fertility Consultants is No. 1 for fertility and surrogacy services; OHSU also ranks among the top five among hospitals and birth centers, and for pregnancy and post-partum support.

Oregon has among the highest prevalence of problem drinking in the country. The story, which features the mother of an OHSU pharmacy tech who died in 2020, notes that 2,153 Oregonians died last year of alcohol-related causes—more than twice the number of people killed by methamphetamines, heroin and fentanyl combined.

The OHSU Casey Eye Institute Outreach Program and other organizations offered free health services during the Nigerian (Igbo) Medical Fair on Sept. 9.

The San Diego Union-Tribune reports that Autobahn Therapeutics has raised $32.7 million in financing to develop a therapy for treatment-resistant depression, noting that the startup was founded on the strength of research led by Tom Scanlan, Ph.D., for central nervous system disorders.